Yondelis

Trabectedin (Yondelis) is a chemotherapy medication used for treating certain types of soft tissue sarcoma and ovarian cancer. Administered intravenously, it targets cancer cells to slow disease progression. This overview covers key details for informational purposes only.

Trabectedin is primarily used to treat advanced soft tissue sarcoma when other treatments have not worked. It is also prescribed for relapsed ovarian cancer in combination with another medication. Patients often ask, 'what is Trabectedin used for' in cases where standard therapies fail to control tumor growth. The drug works by interfering with cancer cell division, offering an option for those with limited alternatives.

Trabectedin may cause side effects such as nausea, fatigue, or decreased appetite. Some patients experience changes in liver function or blood cell counts during treatment. These effects vary by individual and are typically monitored by healthcare providers. The drug’s impact on the body depends on dosage and treatment duration.

Trabectedin requires careful handling and administration by healthcare professionals. Patients should report any signs of infection, unusual bleeding, or severe fatigue immediately. Regular blood tests are often needed to check for side effects. Avoiding close contact with others who are sick is advised during treatment.

Trabectedin can interact with medications that affect liver enzymes, such as certain antibiotics or antifungals. Combining it with strong CYP3A inhibitors may increase side effects. Patients should inform their doctor about all prescriptions, over-the-counter drugs, and supplements before starting Trabectedin. Alcohol and grapefruit products may also interact negatively.